arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Orthofix Medical Inc.

OFIX
$10.27 ▼ -0.34 (-3.20%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

Orthofix Medical Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $415.4M
Dividend Yield
Revenue Growth 1.6%
Op. Margin -7.3%
ROIC -2.2%
FCF / Share $-0.44
Trailing P/E
Price / Book 1.0x
FCF Yield
Debt / Equity 0.51
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$196.71M
↑ +1.6%
Net Income Profit after all expenses
$-20.91M
↑ +60.6%
Operating Margin Operating profit as % of sales
-7.3%
↓ -3367.0% 15th
FCF / Share Free cash flow per share
$-0.44
↑ +7.2%
Long-Term Debt Long-term obligations
$221.34M
↑ +40.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
24
Returns
27
Financial Health
48
Cash Quality
14

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters